| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2008PLoSO...3.1915F |
| P356 | DOI | 10.1371/JOURNAL.PONE.0001915 |
| P932 | PMC publication ID | 2271052 |
| P698 | PubMed publication ID | 18382686 |
| P5875 | ResearchGate publication ID | 5469386 |
| P50 | author | Nicholas Funderburg | Q56562708 |
| Benigno Rodriguez | Q42870636 | ||
| P2093 | author name string | Wei Jiang | |
| Michael M Lederman | |||
| Angel A Luciano | |||
| Scott F Sieg | |||
| P2860 | cites work | TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. | Q51973780 |
| Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. | Q51990275 | ||
| Toll-dependent control mechanisms of CD4 T cell activation. | Q51996404 | ||
| Maintenance of serological memory by polyclonal activation of human memory B cells. | Q52008907 | ||
| Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells | Q57447880 | ||
| Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load | Q58034113 | ||
| Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? | Q70211252 | ||
| HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes | Q72688555 | ||
| Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling | Q80499984 | ||
| Toll-like receptors: linking innate and adaptive immunity | Q81808287 | ||
| CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 | ||
| Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 | ||
| Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 | Q24310398 | ||
| Toll-like receptor control of the adaptive immune responses | Q29547305 | ||
| Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions | Q34078687 | ||
| Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients | Q35575683 | ||
| Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. | Q35828692 | ||
| Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients | Q35833022 | ||
| CD69 is an immunoregulatory molecule induced following activation | Q36061024 | ||
| Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection | Q36229666 | ||
| Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV | Q36369802 | ||
| Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. | Q36399551 | ||
| Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides | Q38289912 | ||
| Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection | Q39737687 | ||
| CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs | Q40307375 | ||
| Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. | Q41611623 | ||
| MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands | Q41877481 | ||
| Early reduction of immune activation in lymphoid tissue following highly active HIV therapy | Q44178152 | ||
| Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement | Q46534179 | ||
| CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population | Q47674962 | ||
| CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency | Q47684550 | ||
| Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia | Q48023288 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| toll-like receptor | Q408004 | ||
| T cell activation | Q14863969 | ||
| P304 | page(s) | e1915 | |
| P577 | publication date | 2008-04-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis | |
| P478 | volume | 3 |
| Q37204104 | A role for TLR signaling during B cell activation in antiretroviral-treated HIV individuals |
| Q36076533 | A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection |
| Q34293455 | A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury |
| Q37162262 | An ENU-induced splicing mutation reveals a role for Unc93b1 in early immune cell activation following influenza A H1N1 infection |
| Q35531527 | Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection |
| Q58609021 | Bystander T Cells: A Balancing Act of Friends and Foes |
| Q92857870 | CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy |
| Q45906567 | Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. |
| Q34171589 | Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients |
| Q28066226 | Close Encounters of Lymphoid Cells and Bacteria |
| Q58122552 | Co-stimulation With TLR7 Agonist Imiquimod and Inactivated Influenza Virus Particles Promotes Mouse B Cell Activation, Differentiation, and Accelerated Antigen Specific Antibody Production |
| Q33700312 | Contrasting roles for TLR ligands in HIV-1 pathogenesis |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q33602906 | Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation. |
| Q33943390 | Cytomegalovirus-specific responses of CD38⁺ memory T cells are skewed towards IFN-γ and dissociated from CD154 in HIV-1 infection |
| Q37349847 | Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients. |
| Q35392417 | Differential adjuvant activities of TLR7 and TLR9 agonists inversely correlate with nitric oxide and PGE2 production |
| Q37122279 | Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy |
| Q89399169 | Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy |
| Q31146636 | Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine |
| Q38788604 | FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells. |
| Q30698666 | FcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression |
| Q34007172 | Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease |
| Q41814282 | HIV Infection and TLR Signalling in the Liver |
| Q36186538 | HIV pathogenesis: the host |
| Q42207253 | HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies. |
| Q36352592 | HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro |
| Q33450665 | HIV-1 RNA dysregulates the natural TLR response to subclinical endotoxemia in Kenyan female sex-workers |
| Q33359564 | HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation |
| Q50130203 | Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis |
| Q40075506 | Host and Viral Factors in HIV-Mediated Bystander Apoptosis |
| Q90740831 | Human labour is associated with altered regulatory T cell function and maternal immune activation |
| Q42285768 | Human β defensin-3 induces chemokines from monocytes and macrophages: diminished activity in cells from HIV-infected persons |
| Q35557198 | Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells |
| Q34707229 | Immunomodulatory effects of polysaccharide from marine fungus Phoma herbarum YS4108 on T cells and dendritic cells. |
| Q37444276 | Immunopathogenesis of AIDS. |
| Q36032021 | Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection |
| Q36952930 | Impaired toll-like receptor 8 signaling in multiple sclerosis |
| Q35214189 | Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age. |
| Q35823171 | Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression |
| Q33597485 | Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation |
| Q36665377 | Increased toll-like receptor signaling pathways characterize CD8+ cells in rapidly progressive SIV infection |
| Q37827571 | Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection? |
| Q33997880 | Innate immune recognition and activation during HIV infection |
| Q37777344 | Insights into the role of Toll-like receptors in modulation of T cell responses |
| Q34145979 | Interferon-alpha administration enhances CD8+ T cell activation in HIV infection |
| Q38234839 | Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies |
| Q36807121 | Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines |
| Q36154801 | Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge. |
| Q34545417 | Mechanisms of HIV-associated lymphocyte apoptosis: 2010 |
| Q33713895 | Microbial translocation and cardiometabolic risk factors in HIV infection |
| Q35872112 | Microbial translocation and microbiome dysbiosis in HIV-associated immune activation |
| Q36558287 | Microbial translocation in the pathogenesis of HIV infection and AIDS. |
| Q36501286 | Microbial translocation, immune activation, and HIV disease |
| Q36089230 | Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurity |
| Q34038531 | Oral infectious diseases: a potential risk factor for HIV virus recrudescence? |
| Q33715552 | Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections |
| Q50450148 | Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients. |
| Q37309633 | Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection |
| Q34056881 | Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals |
| Q92867311 | Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesis |
| Q30235024 | Recent Insights into the HIV/AIDS Pandemic |
| Q34296062 | Reduction of immune activation with chloroquine therapy during chronic HIV infection |
| Q34020121 | Residual immune dysregulation syndrome in treated HIV infection |
| Q35780966 | Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients |
| Q37513027 | Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy |
| Q41849777 | T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replication |
| Q34430776 | T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis |
| Q37215125 | TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells |
| Q45384441 | TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells |
| Q61447562 | TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients |
| Q24644783 | The lymph node in HIV pathogenesis |
| Q53687316 | Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. |
| Q37686199 | Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques |
| Q31057328 | Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis |
Search more.